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Abstract
Women with a known BRCA 1 or BRCA 2 genetic mutation are at an increased risk for the
development of cancer, most commonly breast and uterine types. Risk reduction strategies to
manage cancer risk include increased medical surveillance and various preventive surgeries.
This is a deeply personal decision and one that is influenced by a variety of factors. The aim of
this literature review is to identify the key factors impacting the decision-making process of a
woman with a BRCA mutation and how a woman ultimately decides between the cancer risk
management strategies. Six electronic databases were used to obtain the highest levels of
evidence to answer the clinical question at stake. A total of 13 research articles met inclusion
criteria and were examined for key findings. Upon review of the literature, it is evident that
themes exist when examining the decision-making process of women carrying a BRCA
mutation. The most common factor appearing to influence women’s decisions is when a woman
has experienced a family member diagnosed with cancer or has experienced the death of a family
member from cancer; these women tend to choose a preventive surgery. Other factors that affect
women in their decision-making are their stage of life with regards to relationship status and
parity, the value placed on body image and the female body parts, and a variety of psychosocial
factors. Medical professionals can also heavily influence how women make decisions. The
findings of this review are significant for all health care providers as they engage in shared
decision-making and support women with a BRCA genetic mutation who must decide upon a
risk reducing strategy.
Keywords: BRCA-positive mutation, decision-making, BRCA gene, preventive surgery,
risk reduction strategies, breast cancer, mastectomy, cancer risk management
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Choosing Between Medical Surveillance and Preventive Surgical Interventions Among
Asymptomatic BRCA Positive Women
The average lifetime risk of developing breast cancer for an American woman is
approximately 12%, while the average lifetime risk of developing ovarian cancer is
approximately 2% (ACOG, 2018). The risk of developing breast and ovarian cancer substantially
increases in women who are found to be carriers of the BRCA gene. Women who test positive
for the BRCA mutation have a 50%-80% lifetime risk of being diagnosed with breast cancer by
the age of 85 (Johns et al., 2017). Women with a BRCA1 gene have a 39%-46% risk of
developing ovarian cancer by the age of 70, while women with a BRCA2 gene have a 10%-27%
risk of developing ovarian cancer (ACOG, 2018). Though the statistical odds distinctly
demonstrate an increased risk of cancer among BRCA positive women, how a woman decides to
gauge her own cancer risk and determine a treatment plan varies.
When a woman learns that she is a carrier of a BRCA mutation, the decision-making
process begins. A woman must first understand the options available to reduce cancer risk; this
includes several risk-reducing surgical procedures and multiple methods to increase medical
surveillance. Deciding which option to pursue is a highly personal decision with a myriad of
influencing factors. Previous research has demonstrated that the trajectory of the decisionmaking process follows a traditional medical model and is somewhat monomorphic for all
women; however, more recent literature alludes to the fact that the process is much more
individualized, rooted in the experiences of women’s everyday lives (Hesse-Biber, 2016).
Ultimately, a woman must choose a path that best aligns with her personal desires and values.
Through this literature review, key factors are revealed that affect women in deciding between
preventive surgery and increased medical surveillance to manage cancer risk.
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Background
BRCA Mutation
The BRCA mutation places a woman at an increased risk for hereditary cancers,
most commonly, breast and ovarian cancer (ACOG, 2018). Other cancers that are a possibility
include those in the fallopian tubes, peritoneum, pancreas, and skin (ACOG, 2018). The function
of BRCA1 and BRCA2 genes are to suppress tumors by repairing DNA breaks that can lead to
cancer cell proliferation (ACOG, 2018). If these genes are found to have a mutation, they don’t
work properly which results in accelerated expansion of cells, often resulting in cancer (ACOG,
2018). This is the reason women are at a higher risk for a plethora of cancers when a mutation in
the BRCA1 or BRCA2 gene occurs.
BRCA mutations are transmitted via an autosomal dominant pattern of inheritance from
either parent (USPSTF, 2019). According to the American College of Obstetrics and Gynecology
(2018), anywhere from one in 300 people to one in 800 people are found to have a BRCA1 or
BRCA2 genetic mutation. The most common ethnicities linked to the mutation are Eastern or
Central European Jewish, French Canadian, and Icelandic (ACOG, 2018). Routine testing for the
gene is not recommended; however, certain scenarios should prompt an individual to be tested.
Genetic testing for the BRCA1 and BRCA2 mutation is highly sensitive and specific
(USPSTF, 2019). According to the United States Preventive Services Task Force (2019), testing
for the BRCA1/2 gene should be completed in those with a known family history of the gene,
including male relatives. If the status of the mutation is not known in families, testing should
begin only in individuals with known BRCA-related cancers in order to detect the presence of
the gene (USPSTF, 2019). For women where family history information is limited or unknown,
there is no clear direction for the assessment of the mutation (USPSTF, 2019). Access to genetic
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counseling and recommended interventions for a BRCA mutation should also be considered
prior to testing (USPSTF, 2019).
Once a woman chooses to undergo testing and receives positive results, the
process begins to decipher personal cancer risk and determine optimal treatment outcomes.
Learning of a BRCA mutation is often a stressful experience for women. A woman’s pathway to
making decisions about cancer risk management is complex, highly personal and involves an
array of factors. A review of the literature depicts various factors that play of role in motivating
women to choose between medical surveillance and a preventative surgical procedure.
Surveillance or Surgery
One pathway after discovery of a BRCA positive screen is to participate in ongoing
medical surveillance. This route allows a woman to undergo frequent medical examinations and
imaging to closely monitor for the development of cancer. Specific guidelines exist for the
BRCA positive woman in regards to recommended medical surveillance and/or prophylactic
treatment. The current guidelines by the National Comprehensive Cancer Network (NCCN)
recommend a clinical breast exam by a provider every 6 months, an annual mammogram, and a
breast MRI beginning at age 30 (Johns et al., 2017). The American Society of Breast Surgeons
(2019) differ slightly, recommending those women with hereditary susceptibility should have an
annual MRI starting at age 25 and annual mammography starting at age 30. Women should be
offered yearly supplemental imaging, including contrast-enhanced breast magnetic resonance
imaging, whole-breast ultrasound, molecular breast imaging, and contrast-enhanced
mammography (ASBrS, 2019). Less research has been completed on ovarian cancer
surveillance; therefore, the salpingo-oophorectomy procedure is the recommended approach to
manage cancer risk. (Johns et al., 2017).
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The second pathway to manage cancer risk with a BRCA mutation consists of multiple
surgical options; this includes a single or double mastectomy, a hysterectomy, and a
oophorectomy (Hesse-Biber, 2014). A mastectomy is a procedure that removes the breast
components. Both a total mastectomy and a partial mastectomy exist; however, for purposes of
prophylaxis, a total mastectomy is recommended to prevent any chance of cancer
(Breastcancer.org, 2020). A total hysterectomy is the surgical procedure to remove the uterus and
the cervix (Eske, 2020). This can also be combined with salpingo-oophorectomy which involves
removing one or both of a woman’s ovaries and fallopian tubes (Eske, 2020).
The decision to choose a surgical option is a complex one. Women must first understand
each procedure and weigh the benefits and risks of each one. Women must also consider how
these procedures may affect future fertility and body image; two factors which have different
meaning for every woman. Women should consider body image, the risk of surgical
complications and the potential life expectancy gain (Salhab et al., 2010). A risk-reducing
surgery has been found to significantly decrease the risk of developing breast and ovarian cancer
in high-risk individuals (Portnoy et al., 2015). In fact, risk reduction for breast and ovarian
cancer after prophylactic mastectomy is thought to be 90%, and for salpingo-oophorectomy up to
80% (Johns et al., 2017). If the reduction in cancer risk is proven to be substantial among these
procedures, then why do women opt against them? The review of the literature as described later
in the paper helps answer this question and decipher the decision-making process for women.
Purpose/Clinical Question
Based upon the phenomena of interest, the following clinical question was developed in PIO
format to direct the systematic review of the literature: How do asymptomatic women with a
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BRCA positive mutation choose between medical surveillance and preventive surgical
intervention/procedures?
Clinical Significance for Advanced Practice
Genetic counseling and testing have become increasingly prevalent within the medical
world. Often, the first point of contact for testing or referral is in the primary care setting.
Females will seek the knowledge and advice of providers regarding BRCA genetic testing; this
includes whether to complete the testing, what the results mean, and the options available if
positive results are received. A lack of knowledge surrounding the BRCA gene and how women
make decisions regarding treatment options creates a barrier to providing exceptional care and
maximizing cancer prevention. One participant in a study by Leonarczyk and Mawn (2015)
validated this idea:
Having a place to go where you feel like someone is knowledgeable about all the options
is really helpful, and I felt like my nurse practitioner that I see - I actually seem to be
educating her a bit- in the options and the whole process, and that can give you a little bit
of a sense of – not mistrust, but just feeling, you know, that you aren’t necessarily being
taken care of – that you are kind of guiding the ship. (p. 76)
A patient should not have to feel as though they are educating their health care provider or
navigating the process alone. Advanced practice providers should understand the whole process
and decision-making from a women’s standpoint in order to better guide and support women.
Clinician recommendations are often based solely on physical health outcomes, however
the overall impact on a woman’s self-identity, emotional-well-being, and interpersonal
relationships should also be considered (Howard et al., 2011). While genetic counselors may be
available in some locations to support women, the primary care provider may be the point of
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contact in rural or underserved communities; therefore, having the awareness and knowledge
surrounding decision-making among BRCA positive woman allows the primary care provider to
play a significant role in empowering and supporting these patients.
Methods
An extensive literature search was completed between the dates of October 19,
2020 and November 29, 2020 as it pertains to the clinical question. The databases utilized
in this search included Academic Search Premier, CINAHL, Health Source:
Nursing/Academic Edition, MEDLINE, PubMed, and PsycARTICLES. The topic areas
covered by each database along with the restrictions added to the search criteria are
displayed in Table 1 of the appendix. The dates of each search, the specific search terms,
and the resulting number of hits are included in Table 2 of the appendix. Search term
combinations included “BRCA gene,” “BRCA positive women AND decision making,”
“BRCA mutation AND decision making,” “BRCA gene AND risk reduction strategies,”
BRCA gene AND surgical intervention,” “BRCA gene AND surveillance,” “BRCA
positive AND decision making,” and “preventive surgery AND BRCA gene.” The limits
applied to the search with each database included the dates of 2009 to 2020, the English
language, and peer-reviewed articles.
Once the number of hits for each database were recorded, the author aimed to
analyze results under 50 hits. The titles and abstracts were then reviewed. If the findings
did not directly correlate to the clinical questions at stake, the article was excluded.
Duplicates were also discarded. After excluding articles based upon title and/or abstract,
the remaining articles were then reviewed in entirety. Table 3 in the appendix lists the
articles that were reviewed and the rationale as to why the article was included or
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excluded. Multiple articles were excluded because the study did not specifically address women
who had a BRCA gene mutation. Other articles were excluded because the sample included
patients with diagnosed cancer, while the phenomenon of interest includes asymptomatic
women.
A total of 13 articles were included as they met the following inclusion criteria (a)
subjects were women who carry a BRCA1 or BRCA2 gene mutation, (b) studies address the
factors affecting decision-making in the management of cancer risk, (c) study subjects were
asymptomatic, and (d) preventive surgical options such as mastectomy or salpingooophorectomy were considered. The chosen articles were analyzed for level of evidence, key
findings to answer the clinical question, and contributions to practice. The highest level of
evidence obtained were cohort studies which is classified as Level IV evidence; four of these
studies were included. Two meta-synthesis were included which are Level V evidence. Six of the
articles included were qualitative studies and level VI evidence. For more details regarding the
level of evidence, sample sizes, findings, and implications, see Table 4 in the appendices.
Summary of the Literature
A plethora of factors are brought to the forefront when a woman is faced with a BRCA
genetic mutation. Women must choose between medical surveillance or surgical interventions to
manage their personal cancer risk. How a woman perceives her cancer risk and makes decisions
differs from one woman to the next. For some it is clear, obvious, and straightforward; for others
the decision is complex, troublesome, and taxing. A process that can be determined in a matter of
days for some, can persist for years for others. The following summary of the literature describes
the elements affecting how a woman calculates her cancer risk and ultimately chooses between
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ongoing medical surveillance and a surgical intervention upon receiving news of a positive
BRCA mutation.
Family Cancer History
A review of the literature revealed that the most common contributing factor to the
decision-making process for women is the diagnosis of a close family member with cancer, as
well as the death of a family member due to cancer. In a qualitative study including 64
asymptomatic women with a BRCA-positive mutation, all of the women who chose surveillance
over surgical intervention reported that they had no one close to them die from cancer (HesseBiber & An, 2016). A few of the women in the surveillance category reported having a history of
cancer in a relative; however the individual was not close to them or an emotional connection did
not exist (Hesse-Biber & An, 2016). Interestingly, of the 40 women in this study who had a
mother die from breast cancer, every single one chose preventive surgery over surveillance
(Hesse-Biber & An, 2016).
A cohort study completed by Singh et al. (2013) including 136 unaffected BRCA
mutation carriers further suggests that family history impacts how women make decisions. The
authors noted that even though sizeable research on the benefits of procedures like mastectomy
and bilateral salpingo-oophorectomy exist, still more women opt to continue surveillance;
therefore, the objective of the study was to explore the factors that affect decision-making for
women (Singh et al., 2013). Those most likely to have a mastectomy were the women who had
lost their mother to breast cancer (Singh et al., 2013). Women who had experienced the death of
their mother from pelvic cancer elected for a bilateral salpingo-oophorectomy (Singh et al.,
2013). Overall, the findings were highly suggestive that a family history of cancer impacts how a
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woman calculates her own cancer risk, even more so than actual risk estimations themselves
(Singh et al., 2013).
In a qualitative study including 10 BRCA positive women by McQuirter et al. (2010),
family history of breast and ovarian cancer was again proven to have a profound effect on
woman and alter decision-making. The study concluded that women often reach a “pivotal point”
in decision-making (McQuirter et al., 2010). A previous experience such as cancer in a loved one
is one of the pivotal situations where a decision to have a prophylactic surgery became definitive
(McQuirter et al., 2010). One participant who had learned of her positive genetic mutation and
decided to have a prophylactic mastectomy reported “My sister had a lot of trouble with
chemo[therapy], so knowing what she went through… I don’t want to go through that”
(McQuirter et al., 2010, p. 316). In addition, participants mentioned how the age their mother
was diagnosed affected how they calculated their cancer risk; once they reached that specific age
it felt as though a cancer diagnosis would happen any day (McQuirter et al., 2010). Reflecting on
previous experiences of loved ones appears to instill fear into some women and inspire them to
decisively undergo a preventative surgery.
Johns et al. (2017) completed an observational study through retrospective chart review
including 106 women who were BRCA positive and asymptomatic to better understand how
women make decisions. They concluded that a diagnosis of cancer in a family member before
the age of 50 or the death of a family member from cancer was linked to a decision to undergo
preventive mastectomy (Johns et al., 2017). In their study, 36 of the participants underwent
prophylactic mastectomy, while 70 of them chose surveillance (Johns et al., 2017). Overall, the
occurrence of cancer in a family member plays a critical role for women in their viewpoint of
self-risk ultimately impacting the decision-making process (Johns et al., 2017).
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Life Stage
The life stage of a woman impacts how decisions are made. When considering the
treatment options, a woman must recognize her personal role and responsibility as a mother,
wife, partner, sister, and daughter in the decision-making process (Howard et al., 2011). Women
at younger ages have been shown to make different decisions than women who are older based
on a variety of factors. These factors include relationship status, having children or a desire to
have children in the future, and the personal value placed on body image and the role of the
female body parts. Overall, the breasts and ovaries have multiple functions that women cherish;
therefore, inspiring women to choose medical surveillance over a surgical option.
Johns et al. (2017) found that women under age 30 more often choose surveillance over
prophylactic mastectomy compared to those over age 30. Women under age 30 were recognized
to place value on their breasts because of the desire to breastfeed in the future or for the overall
physical appearance (Johns et al., 2017). For some women, the loss of breasts is associated with
decreased self-esteem and feelings of “disfigurement” (Howard et al., 2011). In addition, women
were concerned about the loss of breast sensitivity and pleasure, early menopause, and
permanent infertility. These are all functional consequences that occur as a results of a riskreducing procedure (Howard et al., 2011). One participant in the study by Howard et al. (2011)
stated the following:
It’s [breast] part of my body. It fed my daughter, it’s part of me. I have a lot of fears and
concerns with having surgery. I know most of them are silly or in my head. I think the
biggest obstacle would be myself. Feeling that I’m not a woman, I’m not attractive. Will
my husband still want me? (p. 509)
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A woman experiences an internal battle with how to adapt to these functional consequences of
risk-reducing surgery further complicating the decision-making process (Howard et al., 2011). It
is important to consider that medical providers may not recommend a risk reducing surgery to
younger populations because of these functional consequences (Johns et al., 2017).
Leonarczyk and Mawn (2015) completed a qualitative study including 15 unaffected
carriers of a BRCA1 or BRCA 2 gene. A theme emerging in their findings was that as the stage
of life shifts for women, so does her risk, as do her attitudes toward significant relationships,
marriage, and childbearing (Leonarczyk & Mawn, 2015). One participant highlighted the
difference in decision-making based upon age:
My daughter, having found out at age twenty-five, and me having found out at age fiftythree is completely different. I was at lunch with two sisters last year and one of ‘em was
married and one of ‘em was single and the single said, “I don’t know what I’m gona do”cause she was still trying to meet guys- so she said “I don’t want to have anything major
done to my body.” But the other sister who was married said “I’m gonna have my kids,
two or three in a row, and then get all of this stuff taken out.” (Leonarczyk & Mawn,
2015, p. 74)
This quote validates how priorities change at different stages of life, ultimately affecting how
women make decisions regarding preventative surgery.
Child status and/or the desire to have children are a major component to decision-making.
Parity appears to be associated with the uptake of a prophylactic surgery (Segerer et al., 2019;
Singh et al., 2013). For a woman with any children at home, surgical interventions were often
found to be the only option since women wanted to be assured they would be around for their
children in the future (Hesse-Biber, 2014). The risk of cancer was too great and these women
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would rather undergo surgery than be faced with the possibility of being unable to watch their
children grow (Hesse-Biber, 2014). Hesse-Biber and An (2016) found that the more guilt a
woman felt about passing the gene along to a child, the more likely she would choose surgery
over surveillance. In addition, those with daughters were more likely than those with only sons to
have preventive surgery, as greater consideration was placed on passing along the BRCA gene to
females (Hesse-Biber & An, 2016).
If a woman has a desire to start a family, have more children, or breastfeed, then
prophylactic mastectomy and/or oophorectomy are automatically removed from the treatment
options. Ovarian cancer surveillance is the only choice for younger, premenopausal women who
desire children because prophylactic oophorectomy results in infertility (Leonarczyk & Mawn,
2015). Leonarczyk and Mawn (2015) reflected on this concept as one of their participants spoke
of her decision to preserve fertility with the following: “I was like- there is no freakin way that
this is gonna take my chance of ever having my own children” (p. 74). This is an important
reason as to why some woman choose surveillance over any risk-reducing surgery. Of note,
some women may choose surveillance for a period of time, and then decide to undergo a riskreducing surgery once they have fulfilled their life aspirations.
Another factor impacting the decision-making process in women with positive BRCA
findings is the level of family support she has. Hesse-Biber & An (2016) discussed that the less
family support a woman experienced, the more likely she would continue with surveillance
instead of risk-reducing surgery. Less family support can result in reduced urgency to make a
decision and ultimately lead to delayed decision-making (Hesse-Biber & An, 2016). Overall,
women are often found confiding in their support systems to determine the right treatment
option. Howard et al. (2011) classified engagement with others as one of the decision-making
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approaches that women use when deciding between treatment options. Women bounced thoughts
off individuals close to them to sort through the complexities of their decision (Howard et al.,
2011).
Psychosocial Factors
The sense of fear harbored in women impacts the decision to undergo risk-reducing
surgery. Hesse-Biber (2014) reported that emotional worry and fear are strong predictors in
BRCA positive women to choose a surgical route. In a study by Portnoy and Loud (2015),
individuals with increased breast cancer worry were found to be four times more likely to
undergo a bilateral mastectomy in comparison to women with less worry. Women sometimes
feel the only option to alleviate worry and fear is to have a surgery and choosing surgery over
surveillance gives them a sense of control and provides comfort that the cancer threat is being
eradicated (Hesse-Biber, 2014). Some women were fearful of becoming too emotionally drained
when it came time to have a routine mammogram or MRI in that it could reveal cancer;
moreover, they preferred a risk-reducing surgery (Hesse-Biber, 2014).
The mental health of a woman affects how she makes decisions. If a women’s
emotional health is suffering, she can’t effectively absorb information or make an informed
decision. For women with high anxiety, it may prevent them from complying with surveillance
guidelines (Padamsee et al., 2017). Those who feel poorly about themselves and their health
were more inclined to choose a surgical intervention (Padamsee et al., 2017). Howard et al.
(2011) found that increased worry and distress led to immediate decision making for some
women in order to prevent further distress, while others waited until their mind was clearer to
focus on the decision at stake.
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A cohort study by Portnoy and Loud (2015) of 120 BRCA positive women looked at
how false-positive breast and ovarian cancer screening test results play a factor in how women
make decisions. The findings demonstrated that false-positive test results from cancer screening
instilled fear in women (Portnoy & Loud, 2015). Across the entire study, however, the worry of a
false positive test result was not clearly linked to choosing a risk-reducing surgery (Portnoy &
Loud, 2015). Overall, the most significant finding was that cancer-specific worry proved to be a
strong predictor of surgery which is consistent with the previously discussed findings (Portnoy &
Loud, 2015).
What drives a woman to feel empowered and how she navigates the acceptance of
increased cancer risk influences treatment decisions. For some women, the belief stands that
“what is going to happen, will happen.” Women with this attitude may choose surveillance over
surgical intervention because they feel cancer is inevitable and it will be dealt with when it
happens. In the study by Hesse-Biber (2014), some of the women who chose surveillance
reported that they integrated a positive BRCA diagnosis into their current life and came to terms
with what it meant, ultimately accepting the mutation as who they are. Some women felt they
would not let a genetic mutation get in the way of their life and they would continue living life
normally (Hesse-Biber, 2014). A response by one woman choosing surveillance over surgery
was “We are a fix-it-up culture and sometimes we can’t fix things. If cancer comes, it comes”
(Hesse-Biber, 2014, p. 778). A common belief held by the women choosing surveillance is that
life is greater than a genetic mutation (Hesse-Biber, 2014). For others, the decision-making was
found to be in the hands of a higher power. These women looked to God or their personal
religious beliefs to help guide them through the process (Hesse-Biber, 2014).
Medical Professional Knowledge and Support
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The recommendation of a health care professional can have a powerful effect on a
woman’s decision-making. The significance of this advice is different among women. Some
women will do extensive research on their own, while others will rely heavily on the medical
professional for advice. A woman’s personality and style of obtaining information can alter how
much trust is placed in the medical provider (McQuirter et al., 2010). The knowledge a health
care professional has regarding the topic also affects how much trust a woman has and her
willingness to partake in shared decision-making. Leonarczyk & Mawn (2015) found that
participants were concerned about the lack of competent providers available to guide them along
their decision-making process; this is particularly true in rural areas. When a lack of knowledge
by the health care provider was sensed, women felt alone and that cancer risk management
decisions fell largely on themselves (Leonarczyk & Mawn, 2015).
Women in one study by Hesse & Biber (2014) expressed how health care professionals
had a heavy influence on their decision-making. One participant felt that her provider
seemed to prefer surgery over surveillance and gave the impression that cancer is inevitable for
the BRCA positive patient (Hesse & Biber, 2014). Women who feel pressured to have surgery
by their health care provider may not consider long-term medical surveillance because of the
influence of the provider. Howard et al. (2011) found that women did not feel the health care
professional offered enough support in the decision-making process. Health care professionals
with more of a nondirect approach in their recommendations complicated the process for these
women and forced them to make the decision on their own (Howard et al., 2011).
A qualitative study by Puski et al. (2018) focused on the involvement of others in the
decision-making process for BRCA positive women. Participants felt strongly about health care
professionals’ engagement throughout the process and several women highlighted how
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collaboration with a physician to interpret their risk led to feelings of reassurance during
decision-making (Puski et al., 2018). Women want to trust their health care provider and confide
in them for risk management decisions (Puski et al., 2018). Overall, the health care professional
is in a powerful position to affect the decision-making process for women.
Gaps in the Literature
The intent of this literature search was to include only asymptomatic women in the
decision-making process. A plethora of articles also included symptomatic women or those who
had current cancer; however, a majority of these articles were excluded. By extending the
population of interest to both symptomatic and asymptomatic women, additional perspectives
could have been included within the evidence cited here. Having a current diagnosis of cancer
significantly impacts decision-making and can alter the findings as these women are often driven
to have surgery because of their diagnosis (Hesse-Biber, 2014). While there is evidence of a
variety of factors contributing to the decision-making process for women carrying a BRCA
mutation, more research is needed on strictly asymptomatic women.
Another point to consider is that some women may choose a surgical option such as a
mastectomy but wait to have a hysterectomy until later in life. These women are incorporating
both a surgical option as well as medical surveillance which complicates the results of the
clinical question. A more consistent approach such as studying decision-making of BRCA
mutation carriers at specific ages may be useful. The limitations of the studies in this literature
review included small sample sizes and participants that consisted of Caucasian, middle to upper
class women. More research is needed to include women of all ethnicities and social classes to
gain a broader understanding and increase the overall strength of the evidence.
Discussion
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Carrying a BRCA mutation is worry-some and anxiety provoking for many women.
Women who carry a BRCA mutation are six times more likely to develop breast cancer than the
average woman, and 28 times more likely to develop ovarian cancer (Johns et al., 2017). A
woman must consider her individual cancer risk and ultimately make life-altering decisions. A
review of the current literature depicts the plethora of factors that affect how women choose
between medical surveillance and preventive surgery. It is important to note that women do not
necessarily consider their cancer risk based on statistical odds, but rather to reframe their risk
based upon a variety of other connections which influences their decision making (Hesse-Biber,
2014). There is no solitary risk-reducing strategy that meets the expectations and concerns of all
women; therefore, a variety of factors must be investigated (Salhab, 2010).
A history of cancer in the family emerged as a powerful influence leading a woman to
choose a preventive surgery. Watching the experiences of a loved one dealing with cancer, or
even the death of a loved one from cancer causes a woman to be more fearful and, in many
cases, leads to a quick, straightforward decision to undergo surgery. The age and stage of life a
woman is in affects how decisions are made. Younger women are often more inclined to partake
in increased medical surveillance which can be explained by multiple factors. Women of
younger ages may not yet have children and desire to have them one day, which automatically
removes an oophorectomy from the treatment options. For some women, maintaining functions
of the breasts such as breastfeeding, providing pleasure, and heightening physical appearance led
them to choose surveillance instead of a preventive surgery. Older women may be more willing
to have a risk-reducing procedure as they are through the child-bearing years and may not place
the same importance on body image.
Other contributing factors impacting the decision-making process include a variety of
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psychosocial factors and the level of influence of the health care professional. The amount of
fear and anxiety one experiences affects how decisions are made; higher levels of worry and
distress over carriage of the BRCA mutation are associated with a higher likelihood of a
preventive surgery. Removing body parts and eliminating a cancer threat is a way to intervene
for women with higher anxiety. For other women, having a BRCA genetic mutation doesn’t
appear to have the same significance. These women will accept the fact that they are carriers of
the mutation and not let the mutation stand in the way or affect how they live their life.
The support and recommendations of the health care provider influence how women
make decisions about treatment options. Women desire a health care professional that is
knowledgeable and able to provide information about risk management. In addition, women
want to foster a trusting relationship with the health care professional so that they can engage in
shared decision-making. Women who did not feel supported by their health care provider feel
alone in the decision-making process. Women who are less decisive about their treatment
decision are more likely to rely heavily on the advice of the medical professional.
Overall, a plethora of factors must be considered when a woman learns of a positive
BRCA genetic mutation and must decide upon treatment options. The journey to reaching a
decision requires women to weigh the pros and cons of each option and consider what is most
important to them. The factors presented in this literature review will help readers understand the
viewpoint of BRCA positive women and potentially help alleviate cancer-related distress for this
population; therefore, informed decisions can be made regarding the risk-reducing strategies.
Future Directions
Implications for Practice
The fear and anxiety of women surrounding a BRCA mutation can significantly impact
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decision-making abilities. With increasing popularity of genetic testing, it is likely that more
women will seek BRCA testing. Health care professionals, including advanced practice nurses,
are in a key position to promote BRCA genetic testing and use their knowledge and expertise to
support women during post-test decision-making. Ultimately, this can lead to earlier
identification of cancer or prevention of cancer and improved health outcomes. Healthcare
providers should have an understanding about the BRCA mutation and the treatment modalities
that are available for BRCA positive patients. Decision-making among BRCA positive women is
not a “one size fits all” type of process; a plethora of factors come into play when deciding on a
strategy to reduce cancer risk (Hesse-Biber, 2014). This literature review identifies the key
factors that contribute to decision-making for the woman carrying a BRCA mutation. By gaining
awareness of these factors, health care providers can have a positive impact on women’s medical
decision-making abilities and improve their overall health outcomes (Hesse-Biber & An, 2016).
In addition, the health care provider can engage in shared decision-making with women resulting
in decreased feelings of isolation during this process.
A crucial consideration for health care providers is having awareness that a history of
cancer in the family significantly impacts women’s decisions. Family cancer experiences for
women may serve to guide decision-making even more so than any statistical odds or other
medical recommendations (Hesse-Biber & An, 2016). Professionals should understand the
impact of the family history and strive to discuss this with patients. Whether it be in discussions
to pursue genetic testing or in providing support for women who have received positive BRCA
results, favorable outcomes can be achieved with regards to cancer prevention. Research
demonstrates the effectiveness of risk-reducing surgeries in preventing cancer; therefore,
education and decisional support may result in increased uptake of these procedures.
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Learning of a positive genetic test result causes acute distress for many women; therefore,
the difficulties of decision-making may be further exacerbated. Women then desire to have more
information about the treatment options and seek help in making decisions (Metcalfe et al.,
2017). Understanding the factors explored by this review of the literature opens up another area
of future development. A standardized tool for decision-making could be used in the clinical
setting to further support and empower women. A randomized control trail by Metcalfe et al.,
(2017) found that a decisional aid utilized for women carrying a BRCA mutation was linked to a
significant decrease in cancer-related distress and decision-making when choosing between
treatment options. The decisional aid was a “15-page self-administered booklet that consists of
key words and illustrative icons to summarize information and data regarding generic risk of
breast cancer in BRCA1 and BRCA2 mutation carriers” (Metcalfe et al., 2017, p. 331). The aid
also included all the breast cancer preventive options available along with the risks and benefits
of each strategy, the types of studies used to evaluate preventive options, and a side-by-side
comparison of the pros and cons of each option (Metcalfe et al., 2017). Standardizing a tool of
this kind to be used in the clinic setting would be highly valuable in decreasing decisional
conflict in women carrying a BRCA mutation.
Implications for Policy
Health care policy changes will help support improved practice. Health care providers
should have access to educational opportunities to further understand genetic testing and how to
engage in shared decision-making to support post-test decisions. Not all individuals have access
to genetic counselors; therefore, the primary care provider must have the ability to provide
assistance too. Armstrong (2020) argues that now is the time for primary care providers to take
responsibility in implementing BRCA genetic testing so that women have the opportunity to
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learn of their risk before a diagnosis of cancer. By increasing funding for educational programs
and training, health care providers will be more knowledgeable in this area of practice while also
increasing access of genetic services in rural communities.
Individuals may lack access to appropriate and effective genetic testing due to
cost. Whether or not insurance covers BRCA genetic testing significantly impacts who is able
to undergo testing. Coverage by Medicaid and individual market plans are particularly
inadequate (Armstrong, 2020). Under the Affordable Care Act, insurance companies are required
to cover testing for women who meet specific criteria such as individuals with a personal cancer
history or with a known family history of the BRCA mutation (Armstrong, 2020). Even under
these circumstances, the process to obtain approval for payment is extensive (Armstrong, 2020).
Increased coverage for testing will be beneficial for a multitude of reasons. For women with
cancer, it will help inform treatment decisions. For women who are asymptomatic, learning of a
positive BRCA mutation leads to either increased medical surveillance or a preventive surgery;
both options result in improved health outcomes by earlier detection of cancer or elimination of
the cancer threat.
Implications for Research
Multiples opportunities for future research exist as previously described through this
review of the literature. More research is needed on strictly asymptomatic women. Since a cancer
diagnosis strongly impacts women’s decisions, it is crucial for future studies to focus on
decision-making for women who have not been diagnosed with cancer. Research studies that
focus on evaluating asymptomatic women have proven to be insightful; however, a greater
number of studies with higher levels of evidence would help influence and expedite changes in
practice and policy.
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In order to gain a deeper understanding of decision-making, future research should aim to
include women of all ethnicities. Individuals of all social classes and backgrounds should also be
included to better capture decision-making from a variety of populations. Upon development of a
standardized tool for decision-making, further research should consist of utilizing the tool in the
practice setting and evaluating its effectiveness in a diverse context. Culture, education level, and
socioeconomic status are all important features to consider for future research.
Conclusion
Although an immense amount of current research on the phenomenon of interest does
not exist, the literature that is available is valuable in answering the clinical question being
examined. The literature demonstrates that an array of factors come into play for women making
decisions about whether a preventive surgery or medical surveillance is the best option for
managing cancer risk with a BRCA mutation. A history of cancer in the family proves to be a
strong indictor in the pursuit for a risk-reducing procedure. In addition, a woman’s life stage and
a variety of psychosocial factors appear to play a critical role in the decision-making process.
The knowledge and support of health care professionals affect how women make decisions.
Overall, the process of decision-making for women is complex and deeply personal. Ultimately,
it is the woman who makes the decision between prevention options; however, they look to
health care professionals for advice in deciding which option to implement. Understanding the
BRCA mutation, the risk reducing strategies, and how women make decisions is vital for health
care providers caring for women impacted by positive BRCA findings. Engaging in shared
decision-making will empower women and encourage favorable health outcomes.
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Appendix
Table 1
Database Search Description
Database (or Search Engine)

Restrictions Added to Search

Dates Included in Database

Academic Search Premier

English Language; Peer Reviewed

2009 to 2020

CINAHL

English Language; Peer Reviewed

2009 to 2020

Health Source: Nursing/Academic Edition

English Language; Peer Reviewed

2009 to 2020

MEDLINE

English language; Peer Reviewed;

2009 to 2020

PUBMED

English Language

2009 to 2020

PsycARTICLES

English Language; Peer Reviewed

2009 to 2020

Table 2
Data Abstraction Process

General Subjects Covered by
Database
Broad range of academic topics,
including nursing
Covers a broad range of nursing and
allied health
Includes all articles in medical
disciplines and particularly nursing and
allied health
Biomedicine and health; Life sciences,
behavioral sciences, chemical sciences,
chemical sciences, and bioengineering
for health care professionals
Includes the topics of medicine, nursing,
dentistry, the health care system, and
preclinical sciences
All print journals; From American
Psychological Association, the APA
Educational Publishing Foundation, the
and Canadian Psychological
Association.
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Date of
Search

Key Words

Results in
CINAHL

Results in
PubMed

10.17.20
10.17.20

“BRCA Gene”
“BRCA Positive Women” AND “Decision Making”
“BRCA Mutation” AND “Decision Making”
“BRCA Gene” AND “Risk reduction strategies.”
“BRCA gene” AND “Surgical Intervention”
“BRCA gene” AND “Surveillance”
“BRCA positive” AND “Decision” OR “Decisionmaking”
“preventive surgery” AND “BRCA GENE”

1952
41
145
28
9
79
76
6

10.24.20
10.24.20
10.25.20
11.19.20

Results in
MEDLINE

2564
50
198
143
256
586
14

Results in
Academic Search
Premier
3038
33
130
28
16
94
62

PschARTCILES

2906
10
27
5
5
55
17

Results in
HealthSourc
e
522
16
48
9
7
14
23

227

64

7

21

1

20
19
23
11
5
12
20

*BOLD= articles reviewed in full for match with systematic review inclusion criteria
Table 3
Characteristics of Literature Included and Excluded
Reference

Included or
Excluded

Rationale

Connors, L.M., Voian, N., Shi, Y., Lally, R.M., & Edge, S. (2014). Decision
making after BRCA genetic testing. Clinical Journal of Oncology Nursing,
18(3), E58-63.
Flippo-Morton, T., Walsh, K., Chambers, K., Amacker-North, L., White, B.,
Sarantou, T., Boselli, D.M., White Jr., R.L. (2015). Surgical decision making
in the BRCA-positive population: Institutional experience and comparison
with recent literature. The Breast Journal, 22(1), 35-44.
Hesse-Biber, S. (2014). The genetic testing experience of BRCA-positive
women: Deciding between surveillance and surgery. Qualitative Health
Research, 24(6), 773-789.
Hesse-Biber, S., & An, C. (2016). Genetic testing and post-testing decision
making among BRCA-positive mutation women: A psychosocial approach.
Journal of Genetic Counseling, 25(5), 978-992.
Howard, A. F., Balneaves, L.G., Bottorff, J.L., & Rodney, P. (2011).
Preserving the self: The process of decision making about hereditary breast
cancer and ovarian cancer risk reduction. Qualitative Health Research, 21(4),
502-519.

Excluded

The study did not require women with BRCA gene; In fact most of
them were negative for the gene.

Excluded

The study includes both patients with cancer and without. It evaluates
the uptake of surgery and surveillance but not necessarily the decision
making factors/process.

Included

Directly evaluates decision-making of treatment options post genetic
testing for BRCA mutation.

Included

Directly analyzed decision-making of women who opted for surgery
or surveillance.

Included

Directly analyzed decision making in risk reducing strategies for
women who are BRCA 1 or BRCA 2 mutation carriers
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Reference

Included or
Excluded

Rationale

Johns, D., Agarwal, J., Anderson, L., Ying, J., & Kohlmann, W. (2017). Breast
cancer reduction decisions of the BRCA- positive patient: An observational
study at a single institution. Journal of Women’s Health, 26(6), 702-706
Leonarczyk, T.J., & Mawn, B. E. (2015). Cancer risk management decision
making for BRCA + women. Western Journal of Nursing Research, 37(1), 6684.
McQuirter, M., Castiglia, L.L., Loiselle, C.G., & Wong, N. (2010). Decisionmaking process of women carrying a BRCA1 or BRCA2 mutation who have
chosen prophylactic mastectomy. Oncology Nursing Forum, 37(3), 313-320
Mellon, S., Janisse, J., Gold, R., Cichon, M., Berry-Bobovski, L., Tainsky,
M.A., & Simon, M.S. (2009). Predictors of decision making in families at risk
for inherited breast/ovarian cancer. Health Psychology, 28(1), 38-47.
Metcalfe, K.A., Dennies, C.L., Poll, A., Armel, S., Demsky, R., Carlsson, L.,
Nanda, S., Kiss, A., & Narod, S.A. (2017). Effect of decision aid for breast
cancer prevention on decisional conflict in women with a BRCA1 or BRCA2
mutation: A multisite, randomized, controlled trial. Genetics in Medicine:
Official Journal of the American College of Medical Genetics, 19(3), 330-336.
Padamsee, T.J., Wills, C.E., Yee, L.D., & Paskett, E.D. (2017). Decision
making for breast cancer prevention among women at elevated risk. Breast
Cancer Research, 19(34), 1-12.
Portnoy, D.B., Loud, J.T., Han, P.K.J., Mai, P.L., & Greene, M.H. (2015).
Effects of false-positive cancer screenings and cancer worry on risk-reducing
surgery among BRCA ½ carriers. Health Psychology, 34(7), 709-717.
Puski, A., Hovick, S., Senter, L., & Toland, A.E. (2018). Involvement and
influence of healthcare providers, family members, and other mutation carriers
in the cancer risk management decision-making process of BRCA1 and
BRCA2 mutation carriers. Journal of Genetic Counseling, 27(5), 1291-1301.
Salhab, M., Bismohun, S., & Mokbel, K. (2010). Risk-reducing strategies for
women carrying BRCA ½ mutations with a focus on prophylactic surgery.
BMC Women’s Health, 10(28),1-10.
Schott, S., Vetter, L., Keller, M., Bruckner, T., Golatta, M., Eismann, S.,
Dikow, N., Evers, C., Sohn, C., & Heil, J. (2017). Women at familial risk of
breast cancer electing for prophylactic mastectomy: frequencies, procedures,
and decision-making characteristics. Archives of Gynecology & Obstetrics,
295(6), 1451-1458

Included

Directly analyzes the factors affecting decision making for managing
breast cancer risk in patients who are BRCA positive

Included

Explored the experience of cancer risk management decision making
for women who are carriers of a BRCA mutation

Included

Looks at the decision-making process of women with BRCA
mutation when they choose prophylactic mastectomy

Excluded

Decision making related to cancer risk not specifically surveillance
verses surgical intervention

Included

A tool is needed in practice to decrease emotional distress that is
experienced among BRCA positive women when making decisions
about treatment options

Included

A review of decision making among women at elevated risk for breast
cancer

Included

Discusses false positive cancer screening results and its effect on
pursuing risk-reducing surgery

Included

Evaluated the decision making process of increased cancer screening
or prophylactic surgery of women with BRCA mutations focusing on
the involvement of others

Included

Summarizes the available literature in regards to risk-reducing
strategies for BRCA positive mutation carriers

Excluded

Does not directly answer PIO question; Looks at all women choosing
preventive mastectomy, not just BRCA positive. Also doesn’t address
the factors contributing to decision making.
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Reference

Included or
Excluded

Rationale

Segerer, R., Peschel, C., Kammerer, U., Haussler, S., Wockel, A., & Segerer,
S. (2020). Decision-making towards prophylactic surgeries in BRCA mutation
carriers and women with familial predisposition. Breast Care, 15(3), 253-259.
Singh, K., Lester, J., Karlan, B., Bresee, C., Geva, T., & Gordon, O. (2013).
Impact of family history on choosing risk-reducing surgery among BRCA
mutation carriers. American Journal of Obstetrics & Gynecology, 208(4), e1e6.
Yadav, S., Jinna, S., Pereira-Rodrigues, O. Reeves, A., Campian, S., Sufka, A.,
& Zakalik, D. (2018). Impact of preoperative BRCA ½ testing on surgical
decision making in patients with newly diagnosed breast cancer. Breast
Journal, 24(4), 541-548

Included

Identifies objective and emotional factors that impact the decision
making process

Included

Investigates factors that influence decision making regarding
prophylactic surgeries among BRCA positive women

Excluded

Analyzes patients with breast cancer rather than asymptomatic
women

Table 4
Literature Review Table of All Studies Included
Citation

Study Purpose

Pop (N)/
Sample Size
(n)
/Setting(s)

Design/ Level of
Evidence

Variables/
Instruments

Intervention

Findings

Implications

Hesse-Biber, S. (2014). The genetic
testing experience of BRCA-positive
women: Deciding between surveillance
and surgery. Qualitative Health Research,
24(6), 773-789.

To analyze the
lived experiences
of BRCA
positive women
who choose
surveillance or a
radical surgical
option

N-64

Qualitative Study
Level VI

Interviews
between 1-1.5
hours,
recorded over
the telephone

N/A

49 women had preventive
surgery and 14 did not .
Those who did not have
surgery felt there was no
guarantee to develop
cancer, and some were still
wishing to have children.
Other barriers were cost,
lack of support from
medical professionals, or
lack of social support.
Women do not follow a
“medical” decision making
model. Instead, women
complete an assessment of
their cancer risk with
contributing factors of
familial history, lived
experience of family
member dying from
cancer, social support, and

Health care professionals and
organizations must understand that
the decision making of BRCA +
women is not a “one size fits all.”
Many factors come into play.
Women have discussed the
struggles of putting their
experiences and decision making
into the medical system that did
not meet their needs. A women’s
perspective must be understood in
order to empower women with
BRCA positive status.

BRCA +
women
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Hesse-Biber, S., & An, C. (2016). Genetic
testing and post-testing decision making
among BRCA-positive mutation women:
A psychosocial approach. Journal of
Genetic Counseling, 25(5), 978-992.

Examines the
role of
demographic
factors in
women’s
decision making
about treatment
options and to
what extent do
psychosocial
factors influence
the time at which
women choose
surgery

N- 303

Howard, A. F., Balneaves, L.G., Bottorff,
J.L., & Rodney, P. (2011). Preserving the
self: The process of decision making about
hereditary breast cancer and ovarian
cancer risk reduction. Qualitative Health
Research, 21(4), 502-519.

To understand
how women
make decisions
regarding risk
reducing
strategies (cancer
screening,
surgerymastectomy,
salpingooophorectomy).

Johns, D., Agarwal, J., Anderson, L.,
Ying, J., & Kohlmann, W. (2017). Breast
cancer reduction decisions of the BRCApositive patient: An observational study at
a single institution. Journal of Women’s
Health, 26(6), 702-706

To understand
the factors
affecting the
decisions for
managing breast
cancer risk made
by patients who
are BRCA
mutation positive
and cancer free

Qualitative Study
Level VI

Online survey

N-22

Qualitative Study
Level VI

Interviews,
lasting 45-90
minutes;
Digitally
recorded and
transcribed
verbatim

N/A

N-106

Retrospective
Cohort Study
Level IV

Chart review,
demographic
and clinical
information
based on
electronic
health record.
A logistic
regression
model was
applied.
Factors
included age,
marital status,

N/A

BRCA+
women

Women at
the
Huntsman
Cancer
Institute
Family
Cancer
Assessment
Clinic at the
University of
Utah

N/A

Multidimensio
nal impact of
cancer risk
assessment
(MICRA) and
BRCA SelfConcept Scale
questionnaire

information from social
network.
Women without children
were more likely to have
the surgery than those with
only sons; Those with
daughters were more
likely to have the surgery.
The more distress a
women was over positive
BRCA results, the less
likely to get surgery and
more likely to continue
surveillance. The more
uncertain about familial
support, the less likely a
woman was to have
preventive surgery. This
was also true for medical
uncertainty. The more
guilty a woman felt about
passing trait to children,
the more likely to undergo
surgery.
Overall, the decisionmaking process is directed
toward preserving self;
These included physical
health, self-identity as a
woman, relationships with
others, and emotional
well-being.

Risk reducing strategy is a
very personal decision;
Age of the patient, relative
with breast cancer or death
of a relative before age 50,
and prophylactic
oophorectomy all pay role
in which reduction
strategy is chosen. Patients
less than 30 often
proceeded with
surveillance. This age
there is greater desire to
keep breasts for

In order to maximize cancer
prevention strategies, clinicians
must understand the decision
making from a women’s
standpoint. Utilizing a feminist
approach that highlights specific
psychosocial factors in regards to
medical decision making for risk
reducing surgery is an important
step forward. It may empower
women’s medical decision making
abilities and improve overall
outcomes.

The findings of preserving self
provides direction of decision
support. A women’s decision goes
beyond strictly physical health and
includes a woman’s self-identity,
her emotional well-being, and her
relationships with others.
Information based approaches are
less likely to be successful than
those using psychosocial
interventions that help with coping
and adjustment.
The decision making process is
complex and a highly personal
decision involving a variety of
factors for the provider to
consider.
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Leonarczyk, T.J., & Mawn, B. E. (2015).
Cancer risk management decision making
for BRCA + women. Western Journal of
Nursing Research, 37(1), 66-84.

To explore the
experience of
cancer risk
management
decision making
for women who
are unaffected
carriers of a
BRCA mutation

McQuirter, M., Castiglia, L.L., Loiselle,
C.G., & Wong, N. (2010). Decisionmaking process of women carrying a
BRCA1 or BRCA2 mutation who have
chosen prophylactic mastectomy.
Oncology Nursing Forum, 37(3), 313-320

To look at the
decision making
process of BRCA
+ women who
undergo
prophylactic
mastectomy

Metcalfe, K.A., Dennies, C.L., Poll, A.,
Armel, S., Demsky, R., Carlsson, L.,
Nanda, S., Kiss, A., & Narod, S.A. (2017).
Effect of decision aid for breast cancer
prevention on decisional conflict in
women with a BRCA1 or BRCA2
mutation: A multisite, randomized,
controlled trial. Genetics in Medicine:
Official Journal of the American College
of Medical Genetics, 19(3), 330-336.

BRCA ½ women
must make
critical decisions
in regards to
breast cancer
prevention and
screening; This
study evaluates
the effectiveness
of a decision aid
for breast cancer
prevention in
women with a
BRCA mutation

N-15
Facing our
Risk of
Cancer
Empowered
(FORCE) an
online
informationa
l and support
group
N-10
Recruited
from an
outpatient
cancer
prevention
center in the
oncology
and medical
genetics
departments
of a hospital
in Montreal,
Quebcec,
Canada
N-150
Women
recruited
from 4
genetic clinic
in Canada
and through
online
support
network
based in the
US

Qualitative Study,
phenomenological
Level VI

children,
personal
history of
cancer, family
history of
cancer, death
of relative
from cancer,
obesity, and
oophorectomy
Interviews25-60
minutes; 9 in
person and 6
by telephone;
Videotaped

breastfeeding or
appearance. A personal
family history of cancer
plays an important role in
perceived self-risk. If a
patient undergoes one risk
reducing surgery, they are
more likely to opt for
others.
N/A

Qualitative Study
Level VI

Interviews

N/A

RCT
Level II

Decisional
Conflict Scale
questionnaire
measures a
person’s
difficulty with
decision
making.
Secondary
outcomes
were cancer
related
distress using
IES.

Decisional
aid to
provide
support
regarding
breast cancer
prevention

Fear related to family
experiences with cancer,
body image, and concerns
about fertility are factors
affecting decision making.
Urgency to have intimate
relationships and complete
childbearing before
prophylactic surgery were
other factors.
Pivotal points to
definitively have a
mastectomy were testing
positive for a mutation,
having a personal history
of breast cancer, or having
a family member with
breast cancer. Emotions
play a vital role in decision
making; It is more
complicated than weighing
the pros and cons. Anxiety
and worry come into play.

There is a need for knowledge and
support by health care providers in
this area. Telehealth can connect
support systems to rural
communities where resources are
limited.

The tool did not reduce
decision conflict, but was
effective in decreasing
cancer-related distress in
the year following a
receipt of positive genetic
test results. Cancer related
distress is elevated in the
positive BRCA ½ patient
but it declines over time.
The tool provided lower
levels of long term cancer
related stress in
comparison to usual care.

Utilizing a decisional aid can
better support women and reduce
cancer related distress when
compared with usual care
especially for women who are
undecided about their cancer
prevention strategies.

Awareness of pivotal points may
assist nurses and health care
professionals

34

Padamsee, T.J., Wills, C.E., Yee, L.D., &
Paskett, E.D. (2017). Decision making for
breast cancer prevention among women at
elevated risk. Breast Cancer Research,
19(34), 1-12.

To examine the
various
approaches high
risk women use
in cancer risk
management and
the drivers of
their decisions

N/A

Meta synthesis
Level V

Portnoy, D.B., Loud, J.T., Han, P.K.J.,
Mai, P.L., & Greene, M.H. (2015). Effects
of false-positive cancer screenings and
cancer worry on risk-reducing surgery
among BRCA ½ carriers. Health
Psychology, 34(7), 709-717.

To examine (a)
the effect of
false-positive
breast and
ovarian cancer
screening test
results on
perceived cancer
risk and worry
(b) the joint
effect of FPTR,
risk perception,
and worry on the
choice of surgery

N-170,
women,
breast
screening
with full
BRCA ½
mutation
carrier

Cohort Study
Level IV

To examine gene
carrier decision
making in cancer
risk management
and the role of
others in the
decision making
process

N-20
Database of
patients
previously
seen for
cancer
genetic
counseling

Puski, A., Hovick, S., Senter, L., &
Toland, A.E. (2018). Involvement and
influence of healthcare providers, family
members, and other mutation carriers in
the cancer risk management decisionmaking process of BRCA1 and BRCA2

Qualitative Study
Level VI

Knowledge of
breast cancer
risk via
questionnaire
N/A

N/A

Questionnaire

N/A

Age, race,
ethnicity,
education,
parity, marital
status, and
personal
history of
cancer
The Brief
Symptoms
Inventory-18
anxiety
subscale,
Breast Cancer
worry scale
(Likert type)
Interview
guide;
Recorded and
transcribed
verbatim

N/A

The processing of accurate
information is crucial in
order for women to make
appropriate decisions.
Better informed women
make different decisions in
comparison to those where
shared decision making
did not take place.
Providers often provide
less information than high
risk women want. Intuitive
and emotional decision
making, shaped by
personal experience and
instincts is usually
dominant over the
conscious, analytic style of
decision making.
False positive results were
not associated with opting
for risk-reducing surgery

Research findings can help
support and empower women to
make informed and valueconsistent decisions and move
towards favorable health outcomes

Physicians, family
members, and other
mutation carriers were
found to play an important
role in the decision making
process for surgical
intervention.

Women with BRCA 1 or 2
mutation who have not had
cancer, are under age 40, and/or
do not have current children are
found to have a more difficult
time throughout the decisionmaking process of risk
management. A genetic counselor

BRCA positive women worried
about their cancer risk and in turn
was associated with choosing
surgical management

35
mutation carriers. Journal of Genetic
Counseling, 27(5), 1291-1301.
Salhab, M., Bismohun, S., & Mokbel, K.
(2010). Risk-reducing strategies for
women carrying BRCA ½ mutations with
a focus on prophylactic surgery. BMC
Women’s Health, 10(28),1-10.

may help ease the decision making
process.
Mutation carriers
have multiple
options including
surveillance,
chemoprevention
, and riskreducing surgery;
The aim of this
review is to
provide analysis
and summarize
the available
literature in
relation to riskreducing
strategies.

N/A

Meta-synthesis
Level V

N/A

N/A

Segerer, R., Peschel, C., Kammerer, U.,
Haussler, S., Wockel, A., & Segerer, S.
(2020). Factors impacting on decisionmaking towards prophylactic surgeries in
BRCA mutation carriers and women with
familial predisposition. Breast Care, 15(3),
253-259.

To identify
factors that
impact decision
making process
in BRCA
mutation carriers

n-95 women
with BRCA
mutation

Cohort Study
Level IV

Questionnaire

N/A

Singh, K., Lester, J., Karlan, B., Bresee,
C., Geva, T., & Gordon, O. (2013). Impact
of family history on choosing riskreducing surgery among BRCA mutation
carriers. American Journal of Obstetrics &
Gynecology, 208(4), e1-e6.

Analyzes factors
that influence
decision making
regarding
prophylactic
surgeries among
women with
BRCA mutations

N-136
unaffected
women with
BRCA
mutation

Objective
variables
Psychological
variables

Center in
Los Angeles,
CA

Cohort Study
Level IV

Study subjects
followed for
1-11 years.
Medical
records,
operative
reports, and
family
pedigrees
were
reviewed.
Data collected
included age,
ethnicity,
parity,
mutation type,

N/A

Cancer risk, survival, and
overall quality of life are
the important factors
considered for making a
good decision on riskreducing strategies. Nonsurgical options provide a
good body image and a
quality of life but can be
found to increase risk of
advanced stage cancer and
mortality. The surgical
route ensures high
protection from cancer
however is associated with
a number of disadvantages
of invasiveness, nonreversibility, and surgical
morbidity.
Diagnosed cancer, cancer
in the family, fear of
getting cancer and
assumed better benefits are
factors leading to
preventive surgery.
Reasons for surveillance
include importance of
physical appearance, fear
of rejection of partner, fear
of disordered female
identity, fear of never
feeling healthy again etc.
Family history has a
significant impact on the
uptake of risk-reducing
surgeries among BRCA
mutation carriers. Women
who lost their mother to
breast cancer were more
likely to have riskreducing mastectomy and
those who lost mother to
pelvic cancer were more
likely to have riskreducing bilateral
salpingo-oophorectomy.
Overall, perception of
cancer risk is heavily

The management of BRCA
positive mutation carriers is
challenging; It should consider a
woman’s expectations and
preferences. These preferences
can be informed by good
knowledge or the risk and benefits
of the options considered.

Education on the benefits of
surgery and reducing overall fear
should take place as prophylactic
surgery has been shown to reduce
cancer incidence in comparison to
periodic screening

With the increase in BRCA testing
by primary care providers, the
awareness of subtle factors
beyond statistical risk for cancers
is relevant when providing support
and counseling to at risk women.
Providers should educate the
patient regarding her risk, but also
understand the attitudes
surrounding management options.

36
history of
breast biopsy,
previous
cosmetic
surgery,

associated with a family
history and are motivators
of preventive surgery.
Having children also
found to be associated
with uptake of
prophylactic surgery.

